查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1847802

数位PCR和即时PCR市场按产品类型、技术、样品类型、应用和最终用户划分－2025-2032年全球预测

Digital PCR & Real-Time PCR Market by Product Type, Technology, Sample Type, Application, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，数位 PCR 和即时PCR市场将成长至 306.4 亿美元，复合年增长率为 9.24%。

主要市场统计数据
基准年 2024 151亿美元
预计年份：2025年 164.2亿美元
预测年份：2032年 306.4亿美元
复合年增长率 (%) 9.24%

本文全面探讨了数位PCR和即时PCR的创新如何重新定义实验室诊断、研究工作流程和操作重点。

数位PCR和即时PCR的融合开启了分子分析的新时代，灵敏度、精确度和通量成为实验室性能和临床应用的关键决定因素。即时PCR奠定了核酸定量检测的基准，至今仍是高性能诊断流程和符合监管要求的检测的必备工具。同时，数位PCR作为一种互补技术脱颖而出，能够对低丰度标靶进行绝对定量和卓越的性能，从而应用于从微小残留病灶监测到精确拷贝数变异分析等诸多领域。这些平台共同重塑了诊断、环境监测、食品安全检测和前沿研究应用中的数据可靠性。

在相关人员评估技术采纳方案时，许多实际因素会影响采购和实施选择。仪器占地面积、样本到结果的检测时间、检测方法迁移的便捷性、与实验室资讯系统的整合以及试剂和耗材的可用性都至关重要。此外，不断变化的监管要求和对可靠验证数据的需求也推动了对标准化工作流程和认证试剂的需求。迁移决策正从战术性转向战略层面，实验室需要在营运效率与高解析度定量分析所带来的临床或科学研究价值之间取得平衡。

对塑造分子诊断生态系统的关键转型转变进行深入分析，包括技术应用、工作流程整合和价值链预期。

分子诊断领域正经历着一场变革性的转变，其驱动力包括技术成熟、工作流程整合以及终端使用者期望的改变。随着供应商不断改进通量、自动化和数据分析能力，数位PCR平台正从小众应用走向更广泛的普及，降低了实验室常规部署的门槛。同时，即时PCR系统也不断发展，其热循环速度更快、具备多重PCR功能，并且拥有更完善的软体生态系统，从而简化了检测方法的开发和法规遵从流程。这种双轨发展趋势正在推动混合实验室策略的出现，即团队利用即时PCR进行高性能筛检，而利用数位PCR进行确证或高灵敏度检测。

另一个重大转变是对整合解决方案的需求，这些解决方案需要整合仪器、检验的试剂、软体分析和服务协议。客户现在期望供应商提供端到端的价值，包括简化的侦测转移、远端故障排除和生命週期管理。同时，对分散式检测和更贴近患者的诊断的日益重视，推动了仪器的微型化、加强和简化使用者介面。随着实验室网路的扩展以及检测结果对临床决策的影响，资料完整性和网路安全也变得日益重要，从而推动了对可互通资料系统和符合审核要求的软体功能的需求。

对美国关税调整及其对供应链的影响（截至2025年）所产生的累积营运和策略影响进行严格评估

美国将于2025年实施新的关税政策，这给分子诊断供应链中的製造商、经销商和实验室采购商带来了复杂的营运压力。更高的进口关税和更严格的海关监管增加了国际采购的仪器、试剂和特殊耗材的到岸成本，迫使采购团队重新评估供应商关係和库存策略。为此，一些供应商加快了在地化生产，并扩大了关键试剂的国内采购，以维持价格竞争力并保护自身营运免受关税波动的影响。

除了成本压力外，关税也促使企业采取策略性库存缓衝和长期供应协议，以平稳采购週期并保障临床和研究的连续性。经销商和终端用户正在协商多年定价框架和寄售模式，以稳定供应链。这些调整会对营运产生直接影响，包括增加库存所需的营运成本以及改变采购前置作业时间。中期来看，关税环境可能会促使生产布局重新调整，并使供应链韧性成为策略规划的关键要素。

详细的細項分析揭示了产品类型、技术形式、样品矩阵、应用领域和最终用户画像如何驱动商业性技术优先事项。

细分市场洞察揭示了不同产品类型、技术、样本类型、应用和终端用户之间的细微需求驱动因素，从而影响研发重点和商业化策略。按产品类型划分，仪器因其自动化和高通量而持续受到青睐，而试剂和耗材（例如酶、预混液和探针/引物）则是推动长期盈利的经常性收入的支柱。按技术划分，市场动态由数位PCR和即时PCR的并存构成，其中基于晶片和液滴的数位PCR在灵敏度和样本试样处理通量方面展开竞争，而定量即时PCR和逆转录即时PCR则满足了基因表现和诊断检测的广泛需求。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 在临床诊断中采用多重数位PCR工作流程进行早期癌症突变检测
  • 将基于 CRISPR 的即时PCR检测方法整合到快速照护现场传染病检查中
  • 开发高通量微流体数位PCR平台以加速单细胞分析
  • 利用机器学习演算法提高即时PCR数据解读的诊断准确性
  • 扩大数位PCR检测范围，此检测可直接从检体中进行检测，并减少临床实验室的检体处理时间。
  • 现场环境监测对可携式即时PCR仪的需求日益增长
  • 用于数位PCR的可客製化检测试剂套件能够对研究中的罕见基因变异进行精确定量。
  • 推出灵敏度更高的数位液滴PCR技术，用于非侵入性产前检测。
  • 多重即时PCR检测板的出现，使得医院能够同时检测多种呼吸道病原体。
  • 仪器製造商和试剂供应商携手合作，优化数位化PCR工作流程

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按产品类型分類的数位PCR和即时PCR市场

  • 装置
  • 试剂和耗材
    • 酵素
    • 母带混音
    • 探针和引子
  • 服务
  • 软体

9. 按技术分類的数位PCR和即时PCR市场

  • 数位PCR
    • 基于晶片的数位PCR
    • 液滴式数位PCR
  • 即时PCR
    • 定量即时PCR（qPCR）
    • 逆转录即时PCR（RT-qPCR）

第十章 依样本类型分類的数位PCR和即时PCR市场

  • 血液样本
    • 电浆
    • 血清
  • 环境样品
    • 土壤样本
    • 水样
  • 食品样品
  • 组织样本

第十一章 按应用分類的数位PCR和即时PCR市场

  • 临床应用
    • 传染病检查
    • 肿瘤检测
    • 移植诊断
  • 环境应用
  • 食品安全
    • 过敏原检测
    • 病原体检测
  • 法医学应用
  • 研究用途
    • 基因表现
    • 单细胞分析
    • 干细胞研究

第十二章 依最终用户分類的数位PCR和即时PCR市场

  • 学术研究机构
  • 临床诊断实验室
  • 法医学实验室
  • 製药和生物技术公司

第十三章：按地区分類的数位PCR和即时PCR市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 按组别分類的数位PCR和即时PCR市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国数位PCR与即时PCR市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Abbott Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Analytik Jena GmbH+Co. KG
    • Azure Biosystems Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Biocompare
    • BIOMERIEUX SA
    • Bioneer Corporation
    • Danaher Corporation
    • ELITech Group by Bruker Corp
    • Enzo Life Sciences, Inc.
    • Eppendorf SE
    • Etcon Analytical and Environmental Systems & Services Ltd.
    • Explorea sro
    • F. Hoffmann-La Roche Ltd.
    • Hangzhou Longgene Scientific Instruments Co., Ltd.
    • Heal Force Bio-Meditech Holdings Limited
    • LABGENE Scientific SA
    • Merck KGaA
    • Promega Corporation
    • QIAGEN NV
    • Quidel Corporation
    • R-Biopharm AG
    • RainSure Scientific
    • SD Biosensor, Inc.
    • Solis BioDyne OU
    • STANDARD BIOTOOLS INC.
    • Takara Bio USA, Inc.
    • Thermo Fisher Scientific Inc.
    • Zymo Research Corp.
Product Code: MRR-8760467AA4C1

The Digital PCR & Real-Time PCR Market is projected to grow by USD 30.64 billion at a CAGR of 9.24% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 15.10 billion
Estimated Year [2025] USD 16.42 billion
Forecast Year [2032] USD 30.64 billion
CAGR (%) 9.24%

Comprehensive introduction to how digital PCR and real-time PCR innovations are redefining laboratory diagnostics, research workflows, and operational priorities

The convergence of digital PCR and real-time PCR has accelerated a new era in molecular analysis, where sensitivity, precision, and throughput are key determinants of laboratory performance and clinical impact. Real-time PCR established a baseline for quantitative nucleic acid detection and remains indispensable for high-throughput diagnostic workflows and regulatory-compliant testing. Meanwhile, digital PCR has emerged as a complementary technology that delivers absolute quantification and superior performance for low-abundance targets, enabling applications from minimal residual disease monitoring to precise copy number variation analysis. Together, these platforms are redefining data reliability in diagnostics, environmental surveillance, food safety testing, and advanced research applications.

As stakeholders evaluate technology adoption, several practical considerations shape procurement and implementation choices. Instrument footprint, sample-to-answer turnaround time, ease of assay migration, integration with laboratory information systems, and the availability of reagents and consumables are all critical. In addition, evolving regulatory expectations and the need for robust validation data drive demand for standardized workflows and certified reagents. Transition decisions are increasingly strategic rather than tactical, with laboratories balancing operational efficiency against the clinical or scientific value delivered by higher-resolution quantification.

Detailed analysis of major transformative shifts in technology adoption, workflow integration, and value chain expectations reshaping the molecular diagnostics ecosystem

The molecular diagnostics landscape is undergoing transformative shifts driven by technological maturation, workflow consolidation, and shifting end-user expectations. Digital PCR platforms have moved beyond niche use to broader adoption as vendors refine throughput, automation, and data analysis capabilities, reducing the friction for routine laboratory deployment. Concurrently, real-time PCR systems continue to evolve with faster thermocycling, multiplexing capacity, and enhanced software ecosystems that simplify assay development and regulatory compliance. This dual-track evolution is encouraging hybrid laboratory strategies, where teams deploy real-time PCR for high-throughput screening and digital PCR for confirmatory or high-sensitivity use cases.

Another major shift is the demand for integrated solutions that combine instrumentation, validated reagents, software analytics, and service agreements. Customers now expect vendors to deliver end-to-end value, including simplified assay transfer, remote troubleshooting, and lifecycle management. In parallel, greater emphasis on decentralized testing and near-patient diagnostics is prompting compact, robust instrument formats and simplified user interfaces. Data integrity and cybersecurity are also rising priorities as laboratory networks expand and results drive clinical decision-making, increasing the need for interoperable data systems and audit-ready software functionality.

Rigorous assessment of the cumulative operational and strategic effects resulting from United States tariff adjustments implemented during 2025 and their implications for supply chains

The introduction of new tariff measures by the United States in 2025 has created a complex set of operational pressures for manufacturers, distributors, and laboratory purchasers within the molecular diagnostics supply chain. Increased import duties and broader customs scrutiny have elevated landed costs for instruments, reagents, and specialty consumables sourced internationally, driving procurement teams to reassess supplier relationships and inventory strategies. In response, some vendors have accelerated localization of manufacturing and broadened domestic sourcing for critical reagents to maintain competitive pricing and shield operations from further tariff volatility.

In addition to cost pressures, tariffs have incentivized strategic inventory buffering and longer-term supply agreements to smooth procurement cycles and protect clinical and research continuity. Distributors and end-users are negotiating multi-year pricing frameworks and consignment models to stabilize supply lines. These adjustments have immediate operational implications, including increased working capital requirements for inventory and altered procurement lead times. Over the medium term, the tariff environment is likely to catalyze a redistribution of manufacturing footprints and a renewed focus on supply chain resilience as a key dimension of strategic planning.

In-depth segmentation analysis illuminating how product type, technological format, sample matrix, application area, and end-user profile drive commercial and technical priorities

Segmentation insights reveal nuanced demand drivers across product types, technologies, sample types, applications, and end users that are shaping development priorities and commercialization strategies. Based on product type, instruments continue to command attention for automation and throughput improvements while reagents and consumables such as enzymes, master mixes, and probes and primers remain the recurring revenue backbone that determines long-term profitability; services and software are increasingly offered as value-added components to lock in customer relationships. Based on technology, the market dynamic is defined by the coexistence of digital PCR and real-time PCR, where chip-based and droplet digital PCR formats compete on sensitivity and sample throughput, and where quantitative real-time PCR and reverse transcription real-time PCR sustain broad demand for gene expression and diagnostic assays.

Based on sample type, blood samples including plasma and serum are central to clinical diagnostics and biomarker applications, while environmental samples such as soil and water demand ruggedized workflows for field and surveillance testing; food samples and tissue samples present distinct extraction and assay validation needs that influence reagent formulations and QC processes. Based on application, clinical applications encompass infectious disease testing, oncology testing, and transplant diagnostics, while environmental applications, food safety with allergen and pathogen testing, forensic applications, and research applications such as gene expression, single cell analysis, and stem cell research each have bespoke performance and validation requirements. Based on end user, academic and research institutes emphasize innovation and method development, clinical diagnostics laboratories prioritize throughput and regulatory compliance, forensic labs require chain-of-custody assurance and validation rigor, and pharmaceutical and biotechnology companies seek scalable platforms for both discovery and regulated workflows. Together these segmentation lenses inform product design, pricing strategies, go-to-market planning, and service offerings across the industry.

Comprehensive regional insights describing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence adoption, regulation, and commercial approaches

Regional dynamics are shaping technology adoption, regulatory pathways, and commercial strategies in distinctive ways across core geographies. In the Americas, demand is heavily influenced by clinical laboratory consolidation, payer dynamics, and a strong emphasis on precision diagnostics, driving investment in platforms that deliver clinical-grade data with scalable throughput. North American markets also prioritize rapid assay validation and integration with electronic health record systems, which favors vendors that provide robust documentation and interoperability. Latin American territories exhibit growing public health surveillance needs and are increasingly focused on cost-effective reagent supply and training programs to expand molecular testing access.

In Europe, Middle East & Africa, diverse regulatory frameworks and variable laboratory infrastructures create a mosaic of adoption patterns that require localized regulatory support and flexible service models. Western Europe tends to adopt advanced technologies rapidly due to strong research ecosystems and established clinical networks, whereas parts of the Middle East and Africa emphasize capacity building and partnerships for sustainable testing programs. In the Asia-Pacific region, high-volume testing needs, strong manufacturing capabilities, and rapid commercialization cycles encourage intense competition and fast iteration on instrument features. Several markets in Asia-Pacific are simultaneously scaling decentralized testing and investing in centralized reference laboratories, which opens pathways for both compact point-of-care formats and high-throughput real-time PCR systems.

Strategic company behaviors and competitive positioning insights revealing how technology roadmaps, partnerships, and service models are shaping vendor differentiation

Company strategies across the molecular diagnostics landscape reflect a balance between technological differentiation, commercial reach, and lifecycle support. Leading instrument manufacturers are prioritizing systems that enable seamless assay transfer between real-time and digital platforms, while expanding installed-base service offerings to increase recurring revenue. Reagent suppliers are emphasizing assay standardization and compatibility with multiple instrument ecosystems to lower barriers for customers and to foster brand loyalty. Software and analytics providers are maturing their platforms to provide cloud-enabled data management, advanced curve-fitting algorithms, and compliance-ready audit trails that address both laboratory efficiency and regulatory reporting needs.

Strategic partnerships, targeted acquisitions, and collaborative development agreements are also prominent as companies seek to offer bundled solutions and accelerate time to market for validated assays. Companies that offer comprehensive training programs, strong technical support, and accessible validation resources gain competitive advantage in health systems and research institutions that require rapid adoption with minimal disruption. Finally, firms that invest in regional manufacturing and robust supply chain networks are better positioned to mitigate tariff exposure and to respond to local procurement preferences, creating differentiated value propositions in price-sensitive markets.

Actionable recommendations for industry leaders to enhance resilience, accelerate adoption, and optimize commercial models through product, supply chain, and service innovation

Industry leaders can take pragmatic, high-impact actions to strengthen resilience, accelerate adoption, and capture growth opportunities across diagnostic and research markets. First, prioritize modular product architectures and validated reagent ecosystems that enable customers to scale from proof-of-concept to routine testing without major workflow disruption. This approach reduces friction during procurement and supports longer customer lifecycles. Second, invest in regional manufacturing and diversified supplier networks to mitigate tariff exposure and to ensure continuity of critical reagent and consumable supply, thereby improving price predictability and customer trust.

Third, develop comprehensive service and support packages that include remote diagnostics, training, and co-validation programs to lower the operational burden on customers. Fourth, expand software capabilities that ensure data integrity, interoperability with laboratory information systems, and streamlined regulatory documentation to meet the needs of clinical laboratories. Finally, pursue targeted partnerships with clinical institutions, public health agencies, and research centers to co-develop high-value assays and to demonstrate real-world clinical utility, thereby accelerating uptake and building robust evidence for reimbursement and institutional adoption.

Transparent research methodology detailing interview-driven insights, literature synthesis, and validation steps used to produce actionable intelligence for decision-makers

The research methodology underpinning this analysis combines evidence synthesis, expert validation, and cross-functional triangulation to ensure credibility and relevance. Primary inputs included structured interviews with laboratory leaders, procurement officers, and R&D directors who provided firsthand perspectives on technology selection criteria, workflow constraints, and vendor performance. These qualitative insights were complemented by a systematic review of technical literature, regulatory guidance, product specifications, and recent peer-reviewed studies that document analytical performance characteristics and application outcomes for both digital PCR and real-time PCR platforms.

To ensure robustness, findings were cross-checked with vendor technical documentation and publicly available clinical validation studies. Supply chain and tariff impact assessments were informed by trade policy announcements, import/export trends, and stakeholder interviews with procurement specialists and distribution partners. Throughout the process, key assumptions and illustrative scenarios were validated with subject matter experts to reflect practical implementation realities and to identify critical uncertainties that warrant close monitoring by decision-makers.

Concluding synthesis emphasizing the complementary roles of digital PCR and real-time PCR and the strategic priorities required for sustainable adoption and impact

In summary, the interplay between digital PCR and real-time PCR technologies is creating a versatile toolkit for diagnostics, environmental surveillance, food safety, forensic work, and cutting-edge research. Laboratories are increasingly adopting hybrid strategies that leverage the throughput and regulatory maturity of real-time PCR alongside the sensitivity and absolute quantitation capabilities of digital PCR. At the same time, the 2025 tariff environment has underscored the importance of supply chain diversification, regional manufacturing, and integrated service offerings to protect margins and ensure uninterrupted testing capacity.

Looking ahead, success will hinge on the ability of vendors and laboratory leaders to align technical performance with operational realities, to invest in interoperable software and rigorous validation packages, and to forge collaborative models that demonstrate clinical or scientific value. By focusing on modular product design, resilient procurement strategies, and evidence-based assay development, organizations can capture the benefits of both technologies while navigating policy and market complexity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of multiplex digital PCR workflows for early cancer mutation detection in clinical diagnostics
  • 5.2. Integration of CRISPR-based real-time PCR assays for rapid point-of-care infectious disease testing
  • 5.3. Development of high-throughput microfluidic digital PCR platforms to accelerate single-cell analysis
  • 5.4. Use of machine learning algorithms in real-time PCR data interpretation to improve diagnostic accuracy
  • 5.5. Expansion of direct-from-sample digital PCR tests reducing sample processing time in clinical labs
  • 5.6. Growing demand for portable real-time PCR instruments for on-site environmental monitoring applications
  • 5.7. Customizable assay kits for digital PCR enabling precise quantification of rare genetic variants in research
  • 5.8. Implementation of digital droplet PCR for non-invasive prenatal testing with enhanced sensitivity
  • 5.9. Emergence of multiplex real-time PCR panels for simultaneous detection of respiratory pathogens in hospitals
  • 5.10. Collaboration between instrument manufacturers and reagent suppliers to optimize digital PCR workflows

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Digital PCR & Real-Time PCR Market, by Product Type

  • 8.1. Instruments
  • 8.2. Reagents & Consumables
    • 8.2.1. Enzymes
    • 8.2.2. Master Mixes
    • 8.2.3. Probes & Primers
  • 8.3. Services
  • 8.4. Software

9. Digital PCR & Real-Time PCR Market, by Technology

  • 9.1. Digital PCR
    • 9.1.1. Chip-Based Digital PCR
    • 9.1.2. Droplet Digital PCR
  • 9.2. Real-Time PCR
    • 9.2.1. Quantitative Real-Time PCR (qPCR)
    • 9.2.2. Reverse Transcription Real-Time PCR (RT-qPCR)

10. Digital PCR & Real-Time PCR Market, by Sample Type

  • 10.1. Blood Samples
    • 10.1.1. Plasma
    • 10.1.2. Serum
  • 10.2. Environmental Samples
    • 10.2.1. Soil Samples
    • 10.2.2. Water Samples
  • 10.3. Food Samples
  • 10.4. Tissue Samples

11. Digital PCR & Real-Time PCR Market, by Application

  • 11.1. Clinical Applications
    • 11.1.1. Infectious Disease Testing
    • 11.1.2. Oncology Testing
    • 11.1.3. Transplant Diagnostics
  • 11.2. Environmental Applications
  • 11.3. Food Safety
    • 11.3.1. Allergen Testing
    • 11.3.2. Pathogen Testing
  • 11.4. Forensic Application
  • 11.5. Research Applications
    • 11.5.1. Gene Expression
    • 11.5.2. Single Cell Analysis
    • 11.5.3. Stem Cell Research

12. Digital PCR & Real-Time PCR Market, by End-User

  • 12.1. Academic & Research Institutes
  • 12.2. Clinical Diagnostics Laboratories
  • 12.3. Forensic Labs
  • 12.4. Pharmaceutical & Biotechnology Companies

13. Digital PCR & Real-Time PCR Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Digital PCR & Real-Time PCR Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Digital PCR & Real-Time PCR Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories, Inc.
    • 16.3.2. Agilent Technologies, Inc.
    • 16.3.3. Analytik Jena GmbH+Co. KG
    • 16.3.4. Azure Biosystems Inc.
    • 16.3.5. Becton, Dickinson and Company
    • 16.3.6. Bio-Rad Laboratories, Inc.
    • 16.3.7. Biocompare
    • 16.3.8. BIOMERIEUX S.A.
    • 16.3.9. Bioneer Corporation
    • 16.3.10. Danaher Corporation
    • 16.3.11. ELITech Group by Bruker Corp
    • 16.3.12. Enzo Life Sciences, Inc.
    • 16.3.13. Eppendorf SE
    • 16.3.14. Etcon Analytical and Environmental Systems & Services Ltd.
    • 16.3.15. Explorea s.r.o
    • 16.3.16. F. Hoffmann-La Roche Ltd.
    • 16.3.17. Hangzhou Longgene Scientific Instruments Co., Ltd.
    • 16.3.18. Heal Force Bio-Meditech Holdings Limited
    • 16.3.19. LABGENE Scientific SA
    • 16.3.20. Merck KGaA
    • 16.3.21. Promega Corporation
    • 16.3.22. QIAGEN N.V.
    • 16.3.23. Quidel Corporation
    • 16.3.24. R-Biopharm AG
    • 16.3.25. RainSure Scientific
    • 16.3.26. SD Biosensor, Inc.
    • 16.3.27. Solis BioDyne OU
    • 16.3.28. STANDARD BIOTOOLS INC.
    • 16.3.29. Takara Bio USA, Inc.
    • 16.3.30. Thermo Fisher Scientific Inc.
    • 16.3.31. Zymo Research Corp.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. DIGITAL PCR & REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. DIGITAL PCR & REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. DIGITAL PCR & REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA DIGIT